VHL Polyclonal Antibody

Alias:Von Hippel-Lindau disease tumor suppressor;Protein G7;pVHL;

CatalogNo:HJRLT5988

Specifications

50μL;100μL

Delivery date

Spot

Target

VHL

Reactivity

Human,Rat,Mouse,

Application - After Update

IHC,IF,ELISA

MW(Observed)

19-24kD

Host Species

Rabbit

Isotype

IgG

Modify

Unmodified

Recommended dilution ratio

IHC 1:50-200;ELISA 1:10000-20000;IF 1:50-200

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from the N-terminal region of human VHL. AA range:1-50

Specificity

The antibody detects endogenous VHL

Gene name

VHL

Protein name

Von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL)

Organism-1

Human